DUET also promoted improvements in levels of CRP and glucose that have been observed in other more intensive weight loss interventions among cancer survivors, [43,44] though few differences were detected in other biomarkers typically associated with weight loss, i.e., leptin, adiponectin, and insulin [45,46]. The gene discussed is INS; the disease is cancer.